Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of the Neurological Sciences|August 23, 2005
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examinationDiego Franciotta, Carlo Avolio, Elisabetta Capello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2012
Reward responsiveness and fatigue in multiple sclerosisMatteo Pardini, Elisabetta Capello, Frank Krueger, et al.
Diagnostic Microbiology and Infectious Disease|May 10, 2024
Persistence of Treponema pallidum IgM antibodies in serum: What is their meaning?Giulia Ciccarese, Elisabetta Capello, Serena Varesano, et al.
Clinical Neurology and Neurosurgery|June 12, 2020
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot studyGiulia Alessandria, Riccardo Meli, Maria Teresa Infante, et al.
Autoimmunity Reviews|October 11, 2005
B-cell differentiation in the CNS of patients with multiple sclerosisAnna Corcione, Francesca Aloisi, Barbara Serafini, et al.
Journal of the Neurological Sciences|December 17, 2003
Progressive multifocal leukoencephalopathy in an adult patient with ICF syndromeMonica Colucci, Leonardo Cocito, Elisabetta Capello, et al.
Journal of Neuropathology and Experimental Neurology|February 8, 2006
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cellsBarbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 26, 2010
A case of secondary syphilis presenting as optic neuritisMonica Bandettini di Poggio, Alberto Primavera, Elisabetta Capello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2018
Ecological impact of isolated cognitive relapses in MSRiccardo Meli, Luca Roccatagliata, Elisabetta Capello, et al.
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
Pageof 5